lobbying_activities: 2819814

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2819814	fb279c2f-3ae8-437f-9cd8-ca9dad196911	Q2	IMPACT HEALTH POLICY PARTNERS	401104696	HACKENSACK MERIDIAN HEALTH	2022	second_quarter	MED	Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act.	HOUSE OF REPRESENTATIVES,SENATE,White House Office	40000		0	0	2022-07-15T07:30:02-04:00